Biotechnology News

Abivax Announces Launch of Public Offering of American Depositary Shares PARIS, France – June 30, 2026 – 10:45 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or...

Abivax annonce le lancement d’une offre au public d’American Depositary Shares PARIS, France – 30 juin 2026 – 22h45 CEST – Abivax SA (Euronext Paris : FR0012333284 – ABVX) (« Abivax » ou la « Société...

DUBLIN, Ireland and BRIDGEWATER, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease worldwide,...

DURHAM, N.C., June 30, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet...

EMERYVILLE, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted...

Mechelen, Belgium; 30 June 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)...

Mechelen, België; 30 juni 2026, 22.01 CET; gereglementeerde informatie In het kader van het op 9 juni 2026 aangekondigde inkoopprogramma maakt Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

西雅图, July 01, 2026 (GLOBE NEWSWIRE) -- 随着 AGC Biologics 与 Pyramid Pharma Services 建立战略合作伙伴关系，药物开发商现可在美国本土享受更优的全新制药选择。 此次合作将 AGC Biologics 在药物活性成分开发和生产领域的专业技术与 Pyramid...

西雅圖, July 01, 2026 (GLOBE NEWSWIRE) -- 隨著 AGC Biologics 與 Pyramid Pharma Services 建立策略合作關係，藥物開發商迎來了一個在美國開展生產製造的完善新選項。 這項合作結合了 AGC Biologics 在原料藥開發與製造方面的專業知識，以及 Pyramid...

シアトル発, July 01, 2026 (GLOBE NEWSWIRE) -- AGCバイオロジクス (AGC Biologics) がピラミッド・ファーマ・サービシズ (Pyramid Pharma Services) と戦略的パートナーシップを結んだことにより、医薬品開発企業は、米国における製造のための、最適化された新たな選択肢を活用できるようになる。...